News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,403 Results
Type
Article (44139)
Company Profile (468)
Press Release (701776)
Multimedia
Podcasts (142)
Webinars (23)
Section
Business (209497)
Career Advice (2047)
Deals (36210)
Drug Delivery (137)
Drug Development (84111)
Employer Resources (174)
FDA (16786)
Job Trends (15222)
News (354600)
Policy (33306)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2683)
Accelerated approval (48)
Adcomms (30)
Allergies (174)
Alliances (51115)
ALS (216)
Alzheimer's disease (1839)
Antibody-drug conjugate (ADC) (464)
Approvals (17123)
Artificial intelligence (680)
Autoimmune disease (279)
Automation (53)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (330)
Bladder cancer (190)
Brain cancer (74)
Breast cancer (758)
Cancer (5886)
Cardiovascular disease (481)
Career advice (1739)
Career pathing (43)
CAR-T (333)
CDC (58)
Celiac Disease (3)
Cell therapy (907)
Cervical cancer (46)
Clinical research (72598)
Collaboration (2137)
Company closure (5)
Compensation (1393)
Complete response letters (88)
COVID-19 (2800)
CRISPR (115)
C-suite (1141)
Cystic fibrosis (159)
Data (7780)
Decentralized trials (3)
Denatured (45)
Depression (171)
Dermatology (82)
Diabetes (586)
Diagnostics (6971)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (212)
Drug shortages (32)
Duchenne muscular dystrophy (300)
Earnings (93010)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (123024)
Executive appointments (1107)
FDA (20491)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1774)
Gene editing (250)
Generative AI (56)
Gene therapy (759)
GLP-1 (1097)
Government (4827)
Grass and pollen (6)
Guidances (406)
Healthcare (19316)
HIV (80)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (316)
Immuno-oncology (95)
Indications (181)
Infectious disease (3143)
Inflammatory bowel disease (228)
Inflation Reduction Act (17)
Influenza (139)
Intellectual property (292)
Interviews (319)
IPO (16952)
IRA (53)
Job creations (3717)
Job search strategy (1442)
JPM (67)
Kidney cancer (19)
Labor market (97)
Layoffs (595)
Leadership (40)
Legal (8032)
Liver cancer (101)
Longevity (33)
Lung cancer (775)
Lymphoma (430)
Machine learning (60)
Management (59)
Manufacturing (1036)
MASH (192)
Medical device (14065)
Medtech (14174)
Mergers & acquisitions (20490)
Metabolic disorders (1541)
mRNA (224)
Multiple sclerosis (191)
NASH (20)
Neurodegenerative disease (434)
Neuropsychiatric disorders (113)
Neuroscience (3399)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4603)
Now hiring (77)
Obesity (736)
Opinion (310)
Ovarian cancer (217)
Pain (256)
Pancreatic cancer (300)
Parkinson's disease (372)
Partnered (34)
Patents (593)
Patient recruitment (677)
Peanut (62)
People (60980)
Pharmaceutical (80)
Pharmacy benefit managers (33)
Phase 1 (22829)
Phase 2 (32041)
Phase 3 (23657)
Pipeline (8307)
Policy (327)
Postmarket research (2606)
Preclinical (9794)
Press Release (67)
Prostate cancer (302)
Psychedelics (64)
Radiopharmaceuticals (342)
Rare diseases (1122)
Real estate (6078)
Recruiting (71)
Regulatory (25855)
Reports (55)
Research institute (2512)
Resumes & cover letters (355)
Rett syndrome (36)
RNA editing (25)
RSV (88)
Schizophrenia (184)
Series A (303)
Series B (222)
Service/supplier (11)
Sickle cell disease (119)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (48)
Startups (3830)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (88)
The Weekly (94)
Vaccines (1119)
Venture capital (115)
Weight loss (478)
Women's health (125)
Worklife (21)
Date
Today (196)
Last 7 days (905)
Last 30 days (3251)
Last 365 days (31109)
2026 (11655)
2025 (31061)
2024 (36288)
2023 (41011)
2022 (52276)
2021 (56760)
2020 (54918)
2019 (47415)
2018 (35693)
2017 (33022)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (758)
Alabama (97)
Alaska (7)
Arizona (355)
Arkansas (16)
Asia (41115)
Australia (6851)
California (13226)
Canada (3726)
China (1362)
Colorado (571)
Connecticut (584)
Delaware (399)
Europe (90479)
Florida (1962)
Georgia (423)
Hawaii (3)
Idaho (62)
Illinois (1060)
India (89)
Indiana (599)
Iowa (25)
Japan (528)
Kansas (134)
Kentucky (52)
Louisiana (41)
Maine (75)
Maryland (1589)
Massachusetts (9570)
Michigan (361)
Minnesota (719)
Mississippi (6)
Missouri (145)
Montana (35)
Nebraska (29)
Nevada (139)
New Hampshire (89)
New Jersey (3502)
New Mexico (31)
New York (3446)
North Carolina (1738)
North Dakota (9)
Northern California (6587)
Ohio (393)
Oklahoma (23)
Oregon (44)
Pennsylvania (2650)
Puerto Rico (29)
Rhode Island (51)
South America (1126)
South Carolina (85)
South Dakota (2)
Southern California (5196)
Tennessee (210)
Texas (2089)
United States (46898)
Utah (393)
Vermont (1)
Virginia (317)
Washington D.C. (81)
Washington State (1087)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
746,403 Results for "nammi therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nammi Therapeutics, Inc. Announces First Patient Dosed with QXL138AM in a Phase 1 Study Evaluating Advanced Solid Tumors and Multiple Myeloma
November 8, 2024
·
2 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
April 30, 2026
·
10 min read
Press Releases
enGene Announces Name Change to enGene Therapeutics Inc.
April 7, 2026
·
8 min read
Press Releases
Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
August 6, 2024
·
4 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
Press Releases
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
March 10, 2026
·
5 min read
Press Releases
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
March 25, 2026
·
5 min read
Press Releases
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
March 24, 2026
·
5 min read
Press Releases
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
April 17, 2026
·
2 min read
1 of 74,641
Next
